Ocean Biomedical, Inc.

Ocean Biomedical, Inc. is a biopharmaceutical enterprise engaged in licensing, discovering, and conducting clinical development of therapeutic product candidates. The company focuses on progressing preclinical assets through Investigational New Drug-enabling studies and prospective clinical trials, targeting indications such as fibrosis. Ocean Biomedical relies on acquiring licenses from academic institutions and partnering with research organizations, manufacturing suppliers, and healthcare distribution partners to advance and prepare its therapeutic programs for commercialization rather than selling finished products to consumer retail markets.

The company maintains its principal executive offices in Providence, Rhode Island. As an emerging biopharmaceutical development organization, Ocean Biomedical conducts its management and operational coordination through this central facility while managing relationships with external research partners, clinical sites, and service providers across the United States.

Summary of the business section of Ocean Biomedical's latest annual report, written by StockData.

“approximately 1 to 9 people per 1 million individuals worldwide outside of Puerto Rico.”